Solugen logo

Solugen Funding & Investors

Solugen is a venture-backed biotech company that replaces petroleum-based products with plant-derived substitutes. They combine the elements of fermentation with the elements of petrochemical processing to create the carbon negative molecular manufacturing platform. They produces chemicals from bio-based feedstocks and is based on breakthroughs in synthetic biology, metal catalyst engineering, and modular plant design. Its solutions will also address clean water, sustainable materials, safer food, and healthy personal care.

https://www.solugen.bio/

Total Amount Raised: $642,171,008

Solugen Funding Rounds

  • Series D

    $200,000,000

    Series D Investors

    Kinnevik
    Lowercarbon Capital
    Refactor Capital
    Temasek
    Baillie Gifford & Co
    Fifty Years
  • Series B

    $30,000,000

    Series B Investors

    Refactor Capital
    Valor Equity Partners
    Founders Fund
    Fifty Years
  • Series B

    $32,000,000

    Series B Investors

    Founders Fund
    Fifty Years
    Y Combinator
    KdT Ventures
    Refactor Capital
    HNVR B.V.
  • Series A

    $18,771,000

    Series A Investors

    Fifty Years
    Founders Fund
    Refactor Capital
  • Seed

    $4,400,000

    Seed Investors

    Refactor Capital
    Y Combinator
    Liquid 2 Ventures
    Massachusetts Institute of Technology (MIT)
    Fifty Years
    Todd Corenson
    Hack VC
    Investo
    Tuesday Capital
    Cantos
    FundersClub
    KdT Ventures
    Brad Flora
    Soma Capital
    Social Capital
    Matt Bellamy
    Bossa Nova Investimentos
    Ling Wong
    Array Ventures
  • Series C

    $357,000,000

    Series C Investors

    Baillie Gifford & Co
    GIC
    BlackRock
    Temasek
    Ethos Financial Group
Funding info provided by Diffbot.